teresa holden

At Shire, our purpose of enabling people with life-altering conditions to lead better lives is at the center of everything we do. We're continuously looking for opportunities to strengthen our leadership as a global biotech organization developing & delivering best-in-class therapies for patients with rare & specialty conditions, which is evident throughout our fundamental business model focused on four strategic drivers: growth, innovation, efficiency and people.

SE2, an Eldridge Industries portfolio company, is a leading technology and third party administration company focused on the North American life and annuity insurance industry. SE2 has an unmatched track record in optimizing back-office operations to future-proof insurance companies. SE2 combines peerless industry domain knowledge with a leading-edge administration technology platform to help clients launch products rapidly, improve efficiencies, shift to a variable cost model and maximize profits while dramatically improving the customers’ experience. SE2 supports more than 20 direct clients, represents more than 35 carriers in North America and services more than 1,000 life and annuity products. SE2 has approximately $100 billion in assets under administration and has been recognized as an industry-leading innovator.